• Citer

Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC)

par Loi, Sherene ;Michiels, Stefan ;Salgado, Roberto;Sirtaine, N.;Jose, Vinu ;Fumagalli, Debora ;Brown, David Norman ;Kellokumpu-Lehtinen, Pirkko-Liisa;Bono, Petri;Kataja, Vesa;Desmedt, Christine ;Piccart-Gebhart, Martine ;Loibl, Sibylle;Untch, Michael;Denkert, Carsten;Smyth, Mark John;Joensuu, Heikki;Sotiriou, Christos
Référence San Antonio Breast Cancer Symposium - SABCS(36th: December 2013: San Antonio, Tx, USA), online-only Supplement to Cancer Research
Publication Publié, 2013-12

Abstract de conférence

• Détails
• Contenu

Titre:	Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC)
Auteur:	Loi, Sherene; Michiels, Stefan; Salgado, Roberto; Sirtaine, N.; Jose, Vinu; Fumagalli, Debora; Brown, David Norman; Kellokumpu-Lehtinen, Pirkko-Liisa; Bono, Petri; Kataja, Vesa; Desmedt, Christine; Piccart-Gebhart, Martine; Loibl, Sibylle; Untch, Michael; Denkert, Carsten; Smyth, Mark John; Joensuu, Heikki; Sotiriou, Christos
Informations sur la publication:	San Antonio Breast Cancer Symposium - SABCS(36th: December 2013: San Antonio, Tx, USA), online-only Supplement to Cancer Research
Statut de publication:	Publié, 2013-12
Sujet CREF:	Sciences bio-médicales et agricoles
	Médecine pathologie humaine
	Cancérologie
Langue:	Anglais